Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide

Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H (1988) Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37: 1549–1558

Ciaraldi TP, Gilmore A, Olefsky JM, Goldberg M, Heidenrich KA (1990) In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 39: 1056–1062

Kuzuya T, Iwamoto Y, Kosaka K et al. (1991) A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 11: 147–154

Iwamoto Y, Kuzuya T, Matsuda A et al. (1991) Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care 14: 1083–1086

Suter S, Nolan JJ, Wallance P, Gumbiner B, Olefsky JM (1992) Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 15: 193–203

Fujiwara T, Wada M, Fukuda K et al. (1991) Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57 BL/KsJ-db/db mice. Metabolism 40: 1213–1218

Hase J, Kobayashi K, Mitsui K, Yoshizaki M, Tomimori T (1981) The structure-hemolysis relationship of oleanolic acid derivatives and inhibition of the saponin-induced hemolysis with sapogenins. J Pharm Dyn 4: 833–837

Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63

Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP (1985) An improved method for isolation of mouse pancreatic islets. Transplantation 40: 437–438

Okamoto Y, Ishida H, Taminato T et al. (1992) Role of cytosolic Ca2+ in impaired sensitivity to glucose of rat pancreatic islets exposed to high glucose in vitro. Diabetes 41: 1555–1561

Tsuji K, Taminato T, Usami M et al. (1988) Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model. Metabolism 37: 1040–1044

Inagaki N, Yasuda K, Inoue G et al. (1992) Glucose as regulator of glucose transport activity and glucose-transporter mRNA in hamster β-cell line. Diabetes 41: 592–597

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275

Kato A, Miura T, Yano H, Masuda K, Ishida H, Seino Y (1994) Suppressive effects of polygonati rhizoma on hepatic glucose output, GLUT 2 mRNA expression and its protein content in rat liver. Endocrine Journal 41: 139–144

Oka Y, Asano T, Shibasaki Y et al. (1990) Increased liver glucose transporter protein and mRNA in streptozocin-induced diabetic rats. Diabetes 39: 441–446

Laemmli UK (1970) Cleavage of structural proteins during assembly of the head bacteriophage T4. Nature (Lond) 227: 680–685

Thorens B, Sharkar HK, Kaback HR, Lodish HF (1988) Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells. Cell 55: 281–290

Burnette WN (1981) Western blotting electrophoretic transfer of proteins from sodium dodecyl polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioionated protein A. Anal Biochem 112: 195–203

Meda P, Hooghe-Peters EL, Orci L (1980) Monolayer cultures of adult pancreatic islets cells on osmotically disrupted fibroblasts. Diabetes 29: 497–500

Hayashi S, Horie M, Tsuura Y et al. (1993) Disopyramide blocks pancreatic ATP-sensitive K++ channels and enhances insulin release. Am J Physiol 265 (Cell Physiol 34): C337-C342

Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Michael K (1990) A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to cell contact. Cell 63: 251–258

Tsuura Y, Ishida H, Okamoto Y et al. (1992) Impaired glucose sensitivity of ATP-sensitive K++ channels in pancreatic β-cells in streptozotocin-induced NIDDM rats. Diabetes 41: 861–865

Yasuda K, Yamada Y, Inagaki N et al. (1992) Expression of GLUT 1 and GLUT 2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes 41: 76–81

Bell GI, Burant CF, Takeda J, Gould GW (1993) Structure and function of mammalian facilitative sugar transporters. J Biol Chem 268: 19161–19164

Kuzuya T, Kosaka K, Takebe K et al. (1993) An early phase II clinical trial of a new oral hypoglycemic drug, CS-045, in patients with non-insulin dependent diabetes mellitus. J Clin Therap Med 9 [Suppl 3]: 3–18

Schmid-Antomarchi H, De Weille J, Fosset M, Lazdunski M (1987) The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K++ channel in insulin-secreting cells. J Biol Chem 262: 15840–15844

Boyd III AE, Aguilar-Bryan L, Bryan J et al. (1991) Sulfonylurea signal transduction. Recent Prog Horm Res 47: 299–317

Muller G, Wied S (1993) The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. Diabetes 42: 1852–1867